- Poster presentation
- Open Access
Clearance of Sotalol on continuous venovenous haemofiltration
Critical Care volume 9, Article number: P355 (2005)
Sotalol is a non-selective beta blocker with class III antiarrhythmic properties. It is not protein bound and is mostly excreted unchanged in the urine. Both peritoneal dialysis  and haemodialysis  have been successful in treating Sotalol-induced arrhythmias in the prescence of renal failure. Clearance of Sotalol by continuous venovenous haemofiltration (CVVH) is not described. We report a case of massive Sotalol overdose in which CVVH was successfully used.
A 53-year-old lady presented following a deliberate overdose of Sotalol tablets. She was admitted to the ITU in multiple organ failure requiring mechanical ventilation, vasopressors and renal replacement therapy. CVVH was commenced 15 hours after the overdose using an exchange of 6000 ml/hour (approximately 70 ml/kg/hour) on a Baxter 'Aquarius' machine. High-flow CVVH was continued for 48 hours before reducing to 3000 ml/hour. CVVH was required for 21 days in total. The patient was discharged home without significant morbidity 2 months after admission.
Paired plasma and filtrate samples were collected at intervals during the first 24 hours of CVVH. These were analysed for Sotalol concentration using a HPLC assay. Plasma clearance was estimated using the formula C = UV / P, where C = clearance (ml/min), U = filtrate concentration (mg/ml), V = filtrate volume (ml/min) and P = plasma concentration (mg/ml).
See Table 1. Mean clearance = 67.00 ± 6.64 ml/min.
Tang S, et al.: Perit Dial Int. 1997, 17: 207-208.
Van Uum SH, et al.: Nephrol Dial Transplant. 1997, 12: 331-333. 10.1093/ndt/12.2.331
The authors would like to thank Guy's and St Thomas' Medical Toxicology Unit for their assistance with the Sotalol assay.
About this article
Cite this article
Roberts, H., Stallard, N. Clearance of Sotalol on continuous venovenous haemofiltration. Crit Care 9, P355 (2005). https://doi.org/10.1186/cc3418
- Peritoneal Dialysis
- Renal Replacement Therapy
- Multiple Organ Failure
- Beta Blocker